The time has not yet come to remove your chips from the table: Theravance Biopharma Inc. (TBPH)

Theravance Biopharma Inc. (NASDAQ: TBPH) stock fell -1.56% on Monday to $8.86 against a previous-day closing price of $9.00. With 0.63 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.49 million shares. The 52-week range on TBPH shows that it touched its highest point at $12.03 and its lowest point at $8.85 during that stretch. It currently has a 1-year price target of $13.40. Beta for the stock currently stands at 0.44.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TBPH was down-trending over the past week, with a drop of -12.10%, but this was down by -8.00% over a month. Three-month performance dropped to -16.18% while six-month performance fell -13.56%. The stock lost -11.84% in the past year, while it has lost -21.03% so far this year. A look at the trailing 12-month EPS for TBPH yields -1.05 with Next year EPS estimates of -0.40. For the next quarter, that number is -0.21. This implies an EPS growth rate of 66.90% for this year and 51.90% for next year.

Float and Shares Shorts:

At present, 56.68 million TBPH shares are outstanding with a float of 45.84 million shares on hand for trading. On Aug 30, 2023, short shares totaled 9.0 million, which was 17.04% higher than short shares on Jul 30, 2023. In addition to Mr. Rick E. Winningham M.B.A. as the firm’s Chairman & CEO, Ms. Rhonda F. Farnum serves as its Chief Bus. Officer and Sr. VP of Commercial & Medical Affairs.

Institutional Ownership:

Through their ownership of 100.87% of TBPH’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 77.58% of TBPH, in contrast to 22.90% held by mutual funds. Shares owned by individuals account for 123.14%. As the largest shareholder in TBPH with 14.12% of the stake, Weiss Asset Management LP holds 7,457,060 shares worth 7,457,060. A second-largest stockholder of TBPH, The Baupost Group LLC, holds 7,419,226 shares, controlling over 14.05% of the firm’s shares. Madison Avenue Partners LP is the third largest shareholder in TBPH, holding 7,012,226 shares or 13.28% stake. With a 2.60% stake in TBPH, the iShares Russell 2000 ETF is the largest stakeholder. A total of 1,370,641 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 2.32% of TBPH stock, is the second-largest Mutual Fund holder. It holds 1,226,993 shares valued at 11.68 million. Vanguard Small Cap Index Fund holds 1.99% of the stake in TBPH, owning 1,050,408 shares worth 10.0 million.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, TBPH reported revenue of $11.05M and operating income of -$21.51M. The EBITDA in the recently reported quarter was $9.06M and diluted EPS was -$0.11.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TBPH since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With TBPH analysts setting a high price target of $20.00 and a low target of $9.00, the average target price over the next 12 months is $14.25. Based on these targets, TBPH could surge 125.73% to reach the target high and rise by 1.58% to reach the target low. Reaching the average price target will result in a growth of 60.84% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded TBPH stock several times over the past three months with 0 Buys and 8 Sells. In these transactions, 0 shares were bought while 59,202 shares were sold. The number of buy transactions has increased to 14 while that of sell transactions has risen to 35 over the past year. The total number of shares bought during that period was 710,743 while 432,589 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *